Risk of metabolic syndrome and its components in people with schizophrenia and related psychotic disorders, bipolar disorder and major depressive disorder: a systematic review and meta‐analysis

Cited by (1,000)

Items 201–300 of 1,000

1. Mental health multimorbidity and poor quality of life in patients with schizophrenia
   Ish P. Bhalla, Elina A. Stefanovics, Robert Alan Rosenheck · 2018 · Schizophrenia Research
2. The social inclusion of young people with serious mental illness: A narrative review of the literature and suggested future directions
   Andrew Gardner, Kate Filia, Eoin J. Killackey, Sue Cotton · 2018 · Australian & New Zealand Journal of Psychiatry
3. ‘Walk this way’: results from a pilot randomised controlled trial of a health coaching intervention to reduce sedentary behaviour and increase physical activity in people with serious mental illness
   Julie Williams, B. Stubbs, S. Richardson, C. Flower, Lucy Barr-Hamilton, B. Grey, Kathryn Hubbard, Gilda Spaducci, F. Gaughran, T. Craig · 2019 · BMC Psychiatry
4. Clinical, Biochemical and Genetic Variables Associated With Metabolic Syndrome in Patients With Schizophrenia Spectrum Disorders Using Second-Generation Antipsychotics: A Systematic Review
   Marius H. Sneller, Nini de Boer, Sophie Everaars, Max Schuurmans, Sinan Gülöksüz, Wiepke Cahn, Jurjen Justin Luykx · 2021 · Frontiers in Psychiatry
5. Mitochondria could be a potential key mediator linking the intestinal microbiota to depression
   Chen, Jiezhong, Vitetta, Luis · 2020 · Journal of Cellular Biochemistry
6. Improved psychosocial functioning and quality of life in inpatients with severe mental illness receiving a multidisciplinary lifestyle enhancing treatment. The MULTI study II
   Jeroen Deenik, Diederik E. Tenback, Erwin C. P. M. Tak, Ingrid J.M. Hendriksen, Peter N. van Harten · 2018 · Mental health and physical activity
7. Physical activity as a vital sign in patients with schizophrenia: Evidence and clinical recommendations
   Davy Vancampfort, Brendon Stubbs, Michel Probst, Marc D. Binder, Felipe Barreto Schuch, James Mugisha, Philip B. Ward, Simon Rosenbaum · 2016 · Schizophrenia Research
8. Nanocrystal-based drug delivery system of risperidone: lyophilization and characterization
   Dharmesh Gol, Shreya Thakkar, Manju Misra · 2018 · Drug Development and Industrial Pharmacy
9. Predictors of falls and fractures leading to hospitalization in people with schizophrenia spectrum disorder: A large representative cohort study
   Brendon Stubbs, Christoph Mueller, Fiona Gaughran, John Lally, Davy Vancampfort, Sarah E Lamb, Ai Koyanagi, Shalini Sharma, Robert J. Stewart, Gayan Perera · 2018 · Schizophrenia Research
10. Central levels of tryptophan metabolites in subjects with bipolar disorder
    Ada Trepci, Carl M. Sellgren, Erik Pålsson, Lena Brundin, Neda Khanlarkhani, Lilly Schwieler, Mikael Landén, Sophie Erhardt · 2020 · European Neuropsychopharmacology
11. Allostatic load and systemic comorbidities in psychiatric disorders
    Sabine Finlay, Donna Rudd, BRETT M. McDERMOTT, Zóltan Sarnyai · 2022 · Psychoneuroendocrinology
12. Immunometabolic dysregulation is associated with reduced cortical thickness of the anterior cingulate cortex
    van Velzen, Laura S., Schmaal, Lianne, Milaneschi, Yuri, van Tol, Marie-José, van der Wee, Nic J.A., Veltman, Dick J., Penninx, Brenda W.J.H. · 2017 · Brain, Behavior, and Immunity
13. Effects of omega-3 fatty acids on metabolic syndrome in patients with schizophrenia: a 12-week randomized placebo-controlled trial
    Feikang Xu, Weixing Fan, Weiping Wang, Wei Tang, Fuyin Yang, Yi Zhang, Jun Cai, Lisheng Song, Chen Zhang · 2018 · Psychopharmacology
14. Safety and tolerability of lumateperone for the treatment of schizophrenia: a pooled analysis of late-phase placebo- and active-controlled clinical trials
    John Michael Kane, Suresh Durgam, Andrew Satlin, Kimberly E. Vanover, Richard Chen, Robert E. Davis, Sharon L. Mates · 2021 · International Clinical Psychopharmacology
15. The prevalence and clinical correlates of metabolic syndrome and cardiometabolic alterations in 430 drug-naive patients in their first episode of schizophrenia
    Xiaoe Lang, Qinqin Liu, Han-liu Fang, Yongjie Zhou, Mattew T. Forster, Zezhi Li, Xiangyang Zhang · 2021 · Psychopharmacology
16. Exercise program for the management of anxiety and depression in adults and elderly subjects: Is it applicable to patients with post-covid-19 condition? A systematic review and meta-analysis
    Tommaso Piva, Sabrina Masotti, Andrea Raisi, Valentina Zerbini, Giovanni Grazzi, Gianni Mazzoni, Martino Belvederi Murri, Simona Mandini · 2023 · Journal of Affective Disorders
17. Physical Health and Drug Safety in Individuals with Schizophrenia
    Tamara Milka Pringsheim, Martina Ann Kelly, Doug Urness, Michael D. Teehan, Zahinoor Ismail, David Martin Gardner · 2017 · The Canadian Journal of Psychiatry
18. Exercise as a transdiagnostic intervention for improving mental health: An umbrella review
    Marco Solmi, Ilaria Basadonne, Luca Bodini, Simon Rosenbaum, Felipe Barreto Schuch, Lee Smith, Brendon Stubbs, Joseph Firth, Davy Vancampfort, Garcia Ashdown‐Franks et al. · 2025 · Journal of Psychiatric Research
19. Dysfunctional adipose tissue and low-grade inflammation in the management of the metabolic syndrome: current practices and future advances
    Marleen M. J. van Greevenbroek, Casper G. Schalkwijk, Coen D.A. Stehouwer · 2016 · F1000Research
20. Assessing dietary and lifestyle risk factors and their associations with disease comorbidities among patients with schizophrenia: A case-control study from Bahrain.
    H. Jahrami, M. E. Faris, Zahra Saif, L. Hammad · 2017 · Asian Journal of Psychiatry
21. Dietary intake, food addiction and nutrition knowledge in young people with mental illness
    Scott B. Teasdale, Tracy L. Burrows, Tegan Hayes, Cin Y. Hsia, Andrew Watkins, Jackie Curtis, Philip B. Ward · 2019 · Nutrition & Dietetics
22. Increased serum levels of leptin and insulin in both schizophrenia and major depressive disorder: A cross-disorder proteomics analysis
    Nuray Çakici, Mariska Bot, Femke Lamers, Thomas Janssen, Peter J. van der Spek, Lieuwe de Haan, Sabine Bahn, Brenda W.J.H. Penninx, Nico J.M. van Beveren · 2019 · European Neuropsychopharmacology
23. Dietary intake, physical activity and sedentary behaviour patterns in a sample with established psychosis and associations with mental health symptomatology
    Rebecca Martland, Scott B. Teasdale, Robin M. Murray, Poonam Gardner-Sood, Shubulade M Smith, Khalida Ismail, Zerrin Atakan, Kathryn Greenwood, Brendon Stubbs, Fiona Gaughran · 2021 · Psychological Medicine
24. Developing an International Standard Set of Patient-Reported Outcome Measures for Psychotic Disorders
    Emily McKenzie, Lucy E. Matkin, Luz Sousa Fialho, Ifeoma Nneka Emelurumonye, Timea Gintner, Christiana Ilesanmi, Beth Jagger, Shannon Quinney, Elizabeth L. Anderson, Lone Baandrup et al. · 2021 · Psychiatric Services
25. Schizophrenia
    Alkomiet Hasan, Peter Falkai, Isabell Lehmann, Wolfgang Gäebel · 2020 · Deutsches Ärzteblatt international
26. Physical activity correlates among people with psychosis: Data from 47 low- and middle-income countries
    Brendon Stubbs, Davy Vancampfort, Joseph Firth, Mats Å. Hallgren, Felipe Barreto Schuch, Nicola Veronese, Marco Solmi, Fiona Gaughran, Kai G. Kahl, Simon Rosenbaum et al. · 2017 · Schizophrenia Research
27. Is sport an untapped resource for recovery from first episode psychosis? A narrative review and call to action
    Lauren E. Brooke, Ashleigh Peng Lin, Nikos Ntoumanis, Daniel F. Gucciardi · 2018 · Early Intervention in Psychiatry
28. Alterations in body mass index and waist-to-hip ratio in never and minimally treated patients with psychosis: A systematic review and meta-analysis
    Parita Shah, Yusuke Iwata, Fernando Caravaggio, Eric Plitman, Eric E. Brown, Julia Kim, Nathan K. Chan, Margaret Hahn, Gary J. Remington, Philip Gerretsen et al. · 2019 · Schizophrenia Research
29. Network analysis of the relationship between depressive symptoms, demographics, nutrition, quality of life and medical condition factors in the Osteoarthritis Initiative database cohort of elderly North-American adults with or at risk for osteoarthritis
    Marco Solmi, Ai Koyanagi, Trevor Thompson, Michele Fornaro, Christoph Ulrich Correll, Nicola Veronese · 2019 · Epidemiology and Psychiatric Sciences
30. Adjunctive memantine for major mental disorders: A systematic review and meta-analysis of randomized double-blind controlled trials
    Wei Zheng, Xiao-Min Zhu, Qing-E Zhang, Dong-Bin Cai, Xin-Hu Yang, Y Zhou, Gabor Sandor Ungvari, Chee H. Ng, Shu-Hua He, Xiao-Jiang Peng et al. · 2019 · Schizophrenia Research
31. Cardiovascular risk in patients with severe mental illness in Italy
    Virginio Salvi, Andrea Aguglia, Francesco Barone‐Adesi, Davide Bianchi, Chiara Donfrancesco, Filippo Dragogna, Luigi Palmieri, Gianluca Serafini, Mario Amore, Claudio Mencacci · 2020 · European Psychiatry
32. Sex differences in metabolic disorder patterns of first-episode drug-naive patients with schizophrenia
    Yongjie Zhou, Xinxin Song, Yanhong Guo, Xiaoe Lang, Zezhi Li, Xiangyang Zhang · 2020 · Psychoneuroendocrinology
33. C-reactive protein and cardiovascular risk in bipolar disorder patients: A systematic review
    Victoria S. Marshe, Shamira Pira, Outi Mantere, Bert Bosche, Karl Julian Looper, Nathan Herrmann, Daniel J. Müller, Soham Rej · 2017 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
34. All-cause mortality risk in long-acting injectable versus oral antipsychotics in schizophrenia: a systematic review and meta-analysis
    Clàudia Aymerich, Gonzalo Salazar de Pablo, Malein Pacho, Violeta Pérez-Rodríguez, Amaia Bilbao, Lucía Gallego Andrés, Borja Pedruzo, Idoia Castillo-Sintes, Nerea Aranguren, Paolo Fusar‐Poli et al. · 2024 · Molecular Psychiatry
35. Holistic prevention and management of physical health side-effects of psychotropic medication: second report of the Lancet Psychiatry Physical Health Commission
    Sean Halstead, Chloe X. Yap, Nicola Warren, Sri Mahavir Agarwal, Bodyl A. Brand, Sherry Kit Wa Chan, Andrea Cipriani, Christoph Ulrich Correll, Nicolas Andres Crossley, Enrico D’Ambrosio et al. · 2025 · The Lancet Psychiatry
36. Surgical Management of Obesity Among People with Schizophrenia and Bipolar Disorder: a Systematic Review of Outcomes and Recommendations for Future Research
    Youssef Kouidrat, Ali Amad, Brendon Stubbs, Suzan Moore, Fiona Gaughran · 2017 · Obesity Surgery
37. Older Age Bipolar Disorder
    Annemiek Dols, Aartjan T.F. Beekman · 2020 · Clinics in Geriatric Medicine
38. Cardiometabolic risk prediction algorithms for young people with psychosis: a systematic review and exploratory analysis
    Benjamin Ian Perry, Rachel Upthegrove, O. Crawford, Seung-Ho Jang, Edward Lau, I. McGill, E. Carver, Peter Brian Jones, Golam Mohammed Khandaker · 2020 · Acta Psychiatrica Scandinavica
39. Aerobic exercise in severe mental illness: requirements from the perspective of sports medicine
    Peter Falkai, Andrea Schmitt, Christian P. Rosenbeiger, Isabel Maurus, Lisa Hattenkofer, Alkomiet Hasan, Berend Malchow, Pascale Heim-Ohmayer, Martin Halle, Melanie Heitkamp · 2021 · European Archives of Psychiatry and Clinical Neuroscience
40. Evidence for Shared Genetic Aetiology Between Schizophrenia, Cardiometabolic, and Inflammation-Related Traits: Genetic Correlation and Colocalization Analyses
    B. Perry, N. Bowker, S. Burgess, N. Wareham, R. Upthegrove, P. Jones, C. Langenberg, G. Khandaker · 2022 · Schizophrenia Bulletin Open
41. Patient-reported outcomes of lifestyle interventions in patients with severe mental illness: a systematic review and meta-analysis
    Laura M. Pape, Marcel C. Adriaanse, Jelle Kol, Annemieke van Straten, Berno van Meijel · 2022 · BMC Psychiatry
42. The burden of mood-disorder/cerebrovascular disease comorbidity: essential neurobiology, psychopharmacology, and physical activity interventions
    Michele Fornaro, Marco Solmi, Nicola Veronese, Domenico De Berardis, Elisabetta Filomena Buonaguro, Carmine Tomasetti, Giampaolo Perna, Antonio Preti, Mauro Giovanni Carta · 2017 · International Review of Psychiatry
43. From inactivity to becoming physically active: The experiences of behaviour change in people with serious mental illness
    Jackie Hargreaves, Mike P. Lucock, Alison Rodriguez · 2017 · Mental health and physical activity
44. The association between physical activity and depression among individuals residing in Brazil
    Gisele Dias de Oliveira, Sanda Cristina Oancea, Luciana Bertoldi Nucci, Nancy D. Vogeltanz‐Holm · 2017 · Social Psychiatry and Psychiatric Epidemiology
45. Recent findings on subjective well‐being and physical, psychiatric, and social comorbidities in individuals with schizophrenia: A literature review
    Yupeng He, Ayako Tanaka, Taro Kishi, Yuanying Li, Masaaki Matsunaga, Shinichi Tanihara, Nakao Iwata, Atsuhiko Ota · 2022 · Neuropsychopharmacology Reports
46. Glucagon-like peptide-1 receptor-agonists treatment for cardio-metabolic parameters in schizophrenia patients: a systematic review and meta-analysis
    Abdulrhman M. Khaity, Nada Mostafa Al-dardery, Khaled Anwer Albakri, Omar Ahmed Abdelwahab, Mahmoud Tarek Hefnawy, Yaman Shurki Adel Husni Yousef, Ruaa Elsheikh Widaa Taha, Sarya Swed, Wael Hafez, René Hurlemann et al. · 2023 · Frontiers in Psychiatry
47. Genetic evidence for the causal relations between metabolic syndrome and psychiatric disorders: a Mendelian randomization study
    Xue Gao, Yi Qin, Shu Jiao, Junhui Hao, Jian Zhao, Jiale Wang, Yanchao Wen, Tong Wang · 2024 · Translational Psychiatry
48. Serum IL-1ra, a novel biomarker predicting olanzapine-induced hypercholesterolemia and hyperleptinemia in schizophrenia
    Yezhe Lin, Yanmin Peng, Shen He, Jinjie Xu, Yuan Shi, Yousong Su, Cuizhen Zhu, Xinyi Zhang, Rubai Zhou, Donghong Cui · 2018 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
49. Expression of dopamine signaling genes in the post-mortem brain of individuals with mental illnesses is moderated by body mass index and mediated by insulin signaling genes
    Rodrigo Barbachan Mansur, Gabriel R. Fries, Mehala Subramaniapillai, Sophia Frangou, Fernanda G. De Felice, Natalie Rasgon, Bruce S. McEwen, Elisa Macedo Brietzke, Roger S. McIntyre · 2018 · Journal of Psychiatric Research
50. Association between IL-6 and metabolic syndrome in schizophrenia patients treated with second-generation antipsychotics
    Xinyu Fang, Yewei Wang, Yan Chen, Juanjuan Ren, Chen Zhang · 2019 · Neuropsychiatric Disease and Treatment
51. Mental health nurses’ experience of physical health care and health promotion initiatives for people with severe mental illness
    Sofie Lundström, Henrika Jormfeldt, Britt Hedman Ahlström, Ingela Skärsäter · 2019 · International Journal of Mental Health Nursing
52. Increased risk for venous thromboembolism among patients with concurrent depressive, bipolar, and schizophrenic disorders
    Ching‐En Lin, Chi‐Hsiang Chung, Li‐Fen Chen, Wu-Chien Chien · 2019 · General Hospital Psychiatry
53. What is bipolar disorder? A disease model of dysregulated energy expenditure
    Rodrigo Barbachan Mansur, Yena L. Lee, Roger S. McIntyre, Elisa Macedo Brietzke · 2020 · Neuroscience & Biobehavioral Reviews
54. Safety and tolerability of lumateperone 42 mg: An open-label antipsychotic switch study in outpatients with stable schizophrenia
    Christoph Ulrich Correll, Kimberly E. Vanover, Robert E. Davis, Richard Chen, Andrew Satlin, Sharon L. Mates · 2021 · Schizophrenia Research
55. Facts and myths about the use of lithium for bipolar disorder in routine clinical practice: an expert consensus paper
    Andrea Fiorillo, Gaia Sampogna, Umberto Albert, Giuseppe Maina, Giulio Perugi, Maurizio Pompili, Gianluca Rosso, Gabriele Sani, Alfonso Antonio Vincenzo Tortorella · 2023 · Annals of General Psychiatry
56. Tackling mental health: the role of professional football clubs
    Kathryn Curran, Simon Rosenbaum, Daniel Parnell, Brendon Stubbs, Andy Pringle, Jackie Hargreaves · 2016 · Sport in Society
57. Efficacy, safety and tolerability of aripiprazole in bipolar disorder: An updated systematic review and meta-analysis of randomized controlled trials
    Dian‐Jeng Li, Ping‐Tao Tseng, Brendon Stubbs, Che‐Sheng Chu, Han-Yung Chang, Eduard Vieta, Michele Fornaro, Andre Ferrer Carvalho, Marco Solmi, Nicola Veronese et al. · 2017 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
58. Association between fruit and vegetable intake and symptoms of mental health conditions in Mexican Americans.
    Shenghui Wu, Susan P. Fisher‐Hoch, Belinda M. Reininger, Joseph B. McCormick · 2018 · Health Psychology
59. Schizophrenia and Physical Comorbidity.
    Ivona Šimunović Filipčić, Igor Filipčić · 2018 · PubMed
60. DAily time use, Physical Activity, quality of care and interpersonal relationships in patients with Schizophrenia spectrum disorders (DiAPASon): an Italian multicentre study
    Giovanni de Girolamo, Matteo Rocchetti, Ilaria Maria Antonietta Benzi, Sara Agosta, Letizia Casiraghi, Clarissa Ferrari, Nicola De Franceschi, Ambra Macis, Silvia Pogliaghi, Fabrizio Starace · 2020 · BMC Psychiatry
61. Two Hypotheses on the High Incidence of Dementia in Psychotic Disorders
    Katherine Grace Jonas, Anissa Abi‐Dargham, Roman Kotov · 2021 · JAMA Psychiatry
62. Effectiveness of nutrition and dietary interventions for people with serious mental illness: systematic review and meta‐analysis
    Tetyana Rocks, S. Teasdale, Caitlin Fehily, C. Young, Gina Howland, B. Kelly, S. Dawson, F. Jacka, J. Dunbar, A. O'Neil · 2022 · Medical Journal of Australia
63. Risk factors, prevention and treatment of weight gain associated with the use of antidepressants and antipsychotics: a state-of-the-art clinical review
    Marco Solmi, Alessandro Miola, Federico Capone, Simone Pallottino, Mikkel Højlund, Joseph Firth, Dan J. Siskind, Richard I. G. Holt, Olivier Corbeil, Samuele Cortese et al. · 2024 · Expert Opinion on Drug Safety
64. Metabolic syndrome in patients with schizophrenia: Underlying mechanisms and therapeutic approaches (Review)
    Aspasia Manta, Anastasia Georganta, Afroditi Roumpou, Vassilis Zoumpourlis, Demetrios A. Spandidos, Emmanouil N. Rizos, Μelpomeni Peppa · 2025 · Molecular Medicine Reports
65. Correlates of sedentary behavior in 2,375 people with depression from 6 low- and middle-income countries
    Davy Vancampfort, Brendon Stubbs, James Mugisha, Joseph Firth, Felipe Barreto Schuch, Ai Koyanagi · 2018 · Journal of Affective Disorders
66. Association between frailty and its individual components with the risk of falls in patients with schizophrenia spectrum disorders
    Ming‐Tsun Tsai, Shin-Min Lee, Hsing‐Kang Chen, Bojian Wu · 2018 · Schizophrenia Research
67. Orexin-A Levels in Relation to the Risk of Metabolic Syndrome in Patients with Schizophrenia Taking Antipsychotics
    Po‐Yu Chen, Chun-Hsin Chen, Chin‐Kuo Chang, Chung-Feng Kao, Mong‐Liang Lu, Shih‐Ku Lin, Ming‐Chyi Huang, Ling-Ling Hwang, Valeria Mondelli · 2018 · The International Journal of Neuropsychopharmacology
68. Metabolic syndrome and its components in people with intellectual disability: a meta‐analysis
    Davy Vancampfort, Felipe Barreto Schuch, Tine Van Damme, Joseph Firth, Shuichi Suetani, Brendon Stubbs, Debbie Van Biesen · 2020 · Journal of Intellectual Disability Research
69. A systematic review of physical activity policy recommendations and interventions for people with mental health problems in Sub-Saharan African countries
    Davy Vancampfort, Brendon Stubbs, Marc D. Binder, Christy du Plessis, Caleb Ademola Gbiri, Jepkemoi Joanne Kibet, Nancy Eileen Nekoye Wanyonyi, James Mugisha · 2017 · Pan African Medical Journal
70. Contributions of polygenic risk for obesity to PTSD-related metabolic syndrome and cortical thickness
    Erika J. Wolf, Danielle R. Miller, Mark W. Logue, Jennifer A. Sumner, Tawni B. Stoop, Elizabeth C. Leritz, Jasmeet Pannu Hayes, Annjanette Stone, Steven A. Schichman, Regina E. McGlinchey et al. · 2017 · Brain Behavior and Immunity
71. High prevalence of prediabetes and metabolic abnormalities in overweight or obese schizophrenia patients treated with clozapine or olanzapine
    Julie Rask Larsen, Camilla Kara Svensson, Louise Vedtofte, Mathilde S. L. Jakobsen, Hans Søe Riis Jespersen, Michelle Iris Jakobsen, Kamuran Koyuncu, Ole Schjerning, Jimmi Nielsen, Claus Thorn Ekstrøm et al. · 2018 · CNS Spectrums
72. Changing health workforce attitudes to promote improved physical health in mental health service users: Keeping our Staff in Mind (KoSiM)
    Simon Rosenbaum, Philip B. Ward, Rishi Baldeo, Hamish Fibbins, Rebecca Jarman, Oscar Lederman, Amy Perram, Josephine Poole, Elisa Rossimel, Gabriella Smith et al. · 2020 · Health Promotion Journal of Australia
73. Formulation of olanzapine nanosuspension based orally disintegrating tablets (ODT); comparative evaluation of lyophilization and electrospraying process as solidification techniques
    Neelima Anup, Shreya Thakkar, Manju Misra · 2018 · Advanced Powder Technology
74. Tackling obesity in mental health secure units: a mixed method synthesis of available evidence
    Maxine Johnson, Matthew S. Day, Rajesh Moholkar, Paul L. Gilluley, Elizabeth Goyder · 2018 · BJPsych Open
75. Caring for patients with mental disorders in primary care: a qualitative study on French GPs’ views, atittudes and needs
    Maeva Jego-Sablier, Emilia Debaty, Leila Ouirini, Hélène Carrier, Emma Beetlestone · 2018 · Family Practice
76. Clinical characteristics of obstructive sleep apnea in bipolar disorders
    Pierre A. Geoffroy, Jean‐Arthur Micoulaud‐Franchi, Julia Maruani, Pierre Philip, Carole Boudebesse, Chloé Benizri, Sunthavy Yeim, Victoire Benard, Héléna Brochard, Marion Leboyer et al. · 2018 · Journal of Affective Disorders
77. Diet, exercise, and mental disorders − public health challenges of the future
    Klaus W. Lange · 2018 · University of Regensburg Publication Server (University of Regensburg)
78. Improving Cognition to Increase Treatment Efficacy in Schizophrenia: Effects of Metabolic Syndrome on Cognitive Remediation's Outcome
    Marta Bosia, Mariachiara Buonocore, Margherita Bechi, Laura Santarelli, Marco Spangaro, Federica Cocchi, Carmelo Guglielmino, Laura Bianchi, Serena Bringheli, Francesca Bosinelli et al. · 2018 · Frontiers in Psychiatry
79. What is the prevalence, and what are the clinical correlates, of insulin resistance in young people presenting for mental health care? A cross-sectional study
    Elizabeth M. Scott, Joanne Sarah Carpenter, Frank Iorfino, Shane P. M. Cross, Daniel Francis Hermens, Jeanne Gehue, Chloe E. Wilson, Django White, Sharon Linda Naismith, Adam John Guastella et al. · 2019 · BMJ Open
80. Evidence that genes involved in hedgehog signaling are associated with both bipolar disorder and high BMI
    Claudia Pisanu, Michael J. Williams, Diana Maria Ciuculete, Gaia Olivo, Maria Del Zompo, Alessio Squassina, Helgi B. Schiöth · 2019 · Translational Psychiatry
81. Higher prevalence of metabolic syndrome and related factors in patients with first-episode psychosis and schizophrenia: a cross-sectional study in Turkey
    Musa Şahpolat, Mustafa Arı · 2020 · Nordic Journal of Psychiatry
82. Adjunctive berberine reduces antipsychotic‐associated weight gain and metabolic syndrome in patients with schizophrenia: a randomized controlled trial
    MeiYan Chan, Zongshi Qin, Sui‐Cheung Man, Ming Lam, Wing Him Elvis Lai, Roger Ng, Che Kin Lee, Tak Luen Wong, Edwin Ho Ming Lee, Hei Kiu Wong et al. · 2021 · Psychiatry and Clinical Neurosciences
83. Adjunctive lumateperone ( ITI ‐007) in the treatment of bipolar depression: Results from a randomized placebo‐controlled clinical trial
    Trisha M Suppes, Suresh Durgam, Susan G Kozauer, Richard Chen, Hassan D. Lakkis, Robert E. Davis, Andrew Satlin, Kimberly E. Vanover, Sharon L. Mates, Roger S. McIntyre et al. · 2023 · Bipolar Disorders
84. Participative mental health consumer research for improving physical health care: An integrative review
    Brenda Happell, Stephanie B. Ewart, Chris Platania‐Phung, Robert Stanton · 2016 · International Journal of Mental Health Nursing
85. Sleep quality, chronotype and metabolic syndrome components in bipolar disorders during the remission period: Results from the FACE-BD cohort
    Ophélia Godin, Chantal Henry, Marion Leboyer, Jean‐Michel Azorin, V. Aubin, Frank Bellivier, Mircea Polosan, Philippe Courtet, Sébastien Gard, Jean‐Pierre Kahn et al. · 2017 · Chronobiology International
86. The prevalence of metabolic syndrome in patients receiving antipsychotics in Qatar: a cross sectional comparative study
    Samer Hammoudeh, Suhaila Ghuloum, Ziyad Riyad Mahfoud, Arij Yehya, Abdulmoneim Abdulhakam, Azza Al-Mujalli, Mahmoud Ali Zirie, Mohamed Osman Abdel Rahman, Angela Godwin, Noura Younes et al. · 2018 · BMC Psychiatry
87. Is sleep disturbance linked to short- and long-term outcomes following treatments for recurrent depression?
    Boland, Elaine M., Vittengl, Jeffrey R., Clark, Lee Anna, Thase, Michael E., Jarrett, Robin B. · 2020 · Journal of Affective Disorders
88. Assessment and treatment of sleep problems in bipolar disorder—A guide for psychologists and clinically focused review
    Morton, Emma, Murray, Greg · 2020 · Clinical Psychology & Psychotherapy
89. Literature on peer-based community physical activity programmes for mental health service users: a scoping review
    Lorna M. Tweed, Eva N. Rogers, Florence‐Emilie Kinnafick · 2020 · Health Psychology Review
90. Allostatic load, emotional hyper‐reactivity, and functioning in individuals with bipolar disorder
    Aroldo Dargél, Stevenn Volant, Elisa Macedo Brietzke, Bruno Étain, Émilie Olié, Jean‐Michel Azorin, Sebastian Gard, Frank Bellivier, Thierry Bougerol, Jean‐Pierre Kahn et al. · 2020 · Bipolar Disorders
91. Cardiometabolic Risk in First Episode Psychosis Patients
    Jo Smith, Lisa Griffiths, Marie Band, Dominic Horne · 2020 · Frontiers in Endocrinology
92. Prevalence of nonalcoholic fatty liver disease in mental disorder inpatients in China: an observational study
    Qiuyue Ma, Fude Yang, Botao Ma, Wenzhan Jing, Jue Liu, Moning Guo, Juan Li, Zhiren Wang, Min Liu · 2021 · Hepatology International
93. Short-term efficacy and tolerability of lurasidone in the treatment of acute schizophrenia: A meta-analysis of randomized controlled trials
    Wei Zheng, Dong-Bin Cai, Xin-Hu Yang, Lu Li, Qing-E Zhang, Chee H. Ng, Gabor Sandor Ungvari, Xian-Bin Li, Yu-Ping Ning, Yu‐Tao Xiang · 2018 · Journal of Psychiatric Research
94. Prevalence of metabolic syndrome in Iranian patients with schizophrenia: A systematic review and meta-analysis
    Vahid Shojaeimotlagh, Atieh Hashiehbaf, Maryam Karami, Fateme Monjazebi, Reza Ghanei Gheshlagh · 2018 · Diabetes & Metabolic Syndrome Clinical Research & Reviews
95. Overlapping mechanisms linking insulin resistance with cognition and neuroprogression in bipolar disorder
    Ari B. Cuperfain, James L. Kennedy, Vanessa Faria Gonçalves · 2020 · Neuroscience & Biobehavioral Reviews
96. Weight Gain and Metabolic Changes in Patients With First-Episode Psychosis or Early-Phase Schizophrenia Treated With Olanzapine: A Meta-Analysis
    Christoph Ulrich Correll, Mikkel Højlund, Christine E. Graham, Mark S. Todtenkopf, David McDonnell, Adam Simmons · 2023 · The International Journal of Neuropsychopharmacology
97. Qualitative investigation of perceived barriers to and enablers of sport participation for young people with first episode psychosis
    Lauren E. Brooke, Daniel F. Gucciardi, Nikos Ntoumanis, Ashleigh Peng Lin · 2019 · Early Intervention in Psychiatry
98. The report of the joint WPA/CINP workgroup on the use and usefulness of antipsychotic medication in the treatment of schizophrenia
    K. Fountoulakis, H. Moeller, S. Kasper, C. Tamminga, S. Yamawaki, R. Kahn, R. Tandon, C. Correll, A. Javed · 2020 · CNS Spectrums
99. Aerobic endurance training to improve cognition and enhance recovery in schizophrenia: design and methodology of a multicenter randomized controlled trial
    Isabel Maurus, Alkomiet Hasan, Andrea Schmitt, Astrid Roeh, Daniel Keeser, Berend Malchow, Thomas Schneider-Axmann, Martin Hellmich, Sabine Schmied, Moritz Lembeck et al. · 2020 · European Archives of Psychiatry and Clinical Neuroscience
100. Towards precision medicine: What are the stratification hypotheses to identify homogeneous inflammatory subgroups
     Magdalini Ioannou, Marianne Foiselle, Jasmina Mallet, Elissa L. Stam, Ophélia Godin, Caroline Dubertret, Emilie Terro, Iris E. Sommer, Bartholomeus C. M. Haarman, Marion Leboyer et al. · 2020 · European Neuropsychopharmacology